Home
|
August, 2017: 14 26 28 |
![]() Disclaimer - IMPORTANT - Read this first!
8/14/17-Since the prior entry, the following assets have been sold from our core tradable holdings: CNC; HMC; LCII; NVO; RGA; and SNI. These have been bought to replace them: BKE; DSW; GLAD; TOT; TUP; and WPPGY. The resulting new core tradable stocks in our portfolio are: AMGN; BKE; BRK/B; CVS; DSW; GLAD; LKQ; MCK; QCOM; SLB; T; TOT; TUP; VZ; and WPPGY. Since that entry, our liquid assets have fallen $41,132 or 3.20%, to $1,243,064. Our total equities' yield continues to average 2.0% or above and is on track to achieve the year-end target. For 2017 to date, total assets of all kinds have increased $37,149 or 2.46%.
8/26/17-Since the prior entry, the following assets have been sold from our core tradable holdings: GLAD; LKQ; and TUP. These have been bought to replace them: AB; KITE; and NLY. The resulting new core tradable portfolio includes: AB; AMGN; BKE; BRK/B; CVS; DSW; KITE; MCK; NLY; QCOM; SLB; T; TOT; VZ; and WPPGY. Since that last entry, our liquid assets have fallen another $10,016 or 0.81%, to $1,233,048. Our total equities' yield continues to average 2.0% or above and in fact is already well above the year-end target. For 2017 to date, however, total assets of all kinds have increased just $27,274 or 1.81%.
8/28/17-A buyout offer by Gilead Sciences (GILD) of our previously indicated core tradable asset, Kite Pharma. (KITE), has just been announced. Following the maxim that a bird in the hand is worth two in the bush, all our shares of KITE have been sold today for a net profit of 59% since its purchase for our portfolio a few weeks ago. Its place in the basic 15 tradable core holdings is being taken by AEG (a good dividend with low dividend payout ratio, some momentum, reasonable D/E, and low P/S and P/Bk) which expect to purchase in tomorrow's trading. Accordingly, the new basic 15 tradable core holdings are AB; AEG; AMGN; BKE; BRK/B; CVS; DSW; MCK; NLY; QCOM; SLB; T; TOT; VZ; and WPPGY.
Disclaimer and Disclosure StatementNeither I nor Investor's Journal will be responsible for losses by anyone who obtained ideas from this site. This diary is intended for personal interest and general information only. You are advised to do your own research (as well as to consult highly compensated professionals) before spending money on anything. I know of no reason anyone should take my financial musings seriously. At best I am a dedicated amateur providing a bit of investment-related insight and entertainment, at worst an amusing diversion. My wife, Fran, and I may at times own shares of some of the assets mentioned here. But neither of us receive any benefit from reference to them, unless you count the mutual misery when we get it wrong, or the opportunity to gloat when we get it right.
Home | Previous | Next |